{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:50:28Z","timestamp":1788825028917,"version":"build-2803163510"},"reference-count":36,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1536\/ihj.17-695","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T22:26:32Z","timestamp":1533939992000},"page":"996-1001","source":"Crossref","is-referenced-by-count":72,"title":["A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis"],"prefix":"10.1536","volume":"59","author":[{"given":"Takatoyo","family":"Kiko","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiomi","family":"Yoshihisa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"},{"name":"Department of Advanced Cardiac Therapeutics, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Miyata-Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Misaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-34.","DOI":"10.1056\/NEJM199704243361706"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 2011; 7: 546-54.","DOI":"10.5114\/aoms.2011.24118"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lagana SM, Parwani AV, Nichols LC. Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med 2010; 134: 1039-46.","DOI":"10.5858\/2009-0274-RA.1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Isobe M, Tezuka D. Isolated cardiac sarcoidosis: clinical characteristics, diagnosis and treatment. Int J Cardiol 2015; 182: 132-40.","DOI":"10.1016\/j.ijcard.2014.12.056"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kandolin R, Lehtonen J, Graner M, <i>et al<\/i>. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270: 461-8.","DOI":"10.1111\/j.1365-2796.2011.02396.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996; 10: 495-510.","DOI":"10.1007\/BF00050989"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Youssef G, Leung E, Mylonas I, <i>et al<\/i>. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012; 53: 241-8.","DOI":"10.2967\/jnumed.111.090662"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kiko T, Masuda A, Nemoto A, <i>et al<\/i>. Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET\/MRI. J Nucl Cardiol 2018; 25: 685-7.","DOI":"10.1007\/s12350-017-1066-x"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation. Chest 2014; 146: 1064-72.","DOI":"10.1378\/chest.14-0139"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Greulich S, Deluigi CC, Gloekler S, <i>et al<\/i>. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-11.","DOI":"10.1016\/j.jcmg.2012.10.021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Blankstein R, Osborne M, Naya M, <i>et al<\/i>. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014; 63: 329-36.","DOI":"10.1016\/j.jacc.2013.09.022"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mc Ardle BA, Birnie DH, Klein R, <i>et al<\/i>. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by <sup>18<\/sup>F-fluorodoexyglucose positron emission tomography? Circ Cardiovasc Imaging 2013; 6: 617-26.","DOI":"10.1161\/CIRCIMAGING.112.000289"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Casanova N, Zhou T, Knox KS, Garcia JGN. Identifying Novel Biomarkers in Sarcoidosis Using Genome-Based Approaches. Clin Chest Med 2015; 36: 621-30.","DOI":"10.1016\/j.ccm.2015.08.005"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 2003; 124: 186-95.","DOI":"10.1378\/chest.124.1.186"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yasutake H, Seino Y, Kashiwagi M, Honma H, Matsuzaki T, Takano T. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. Int J Cardiol 2005; 102: 259-68.","DOI":"10.1016\/j.ijcard.2004.05.028"},{"key":"16","unstructured":"16. Handa T, Nagai S, Ueda S, <i>et al<\/i>. Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 27-35."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kandolin R, Lehtonen J, Airaksinen J, <i>et al<\/i>. Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis. Am J Cardiol 2015; 116: 960-4.","DOI":"10.1016\/j.amjcard.2015.06.021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Baba Y, Kubo T, Kitaoka H, <i>et al<\/i>. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J 2012; 53: 287-92.","DOI":"10.1536\/ihj.53.287"},{"key":"19","unstructured":"19. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J 2011; 75: 734-43.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Elliott P, Andersson B, Arbustini E, <i>et al<\/i>. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-6.","DOI":"10.1093\/eurheartj\/ehm342"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Richardson P, McKenna W, Bristow M, <i>et al<\/i>. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-2.","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lang RM, Bierig M, Devereux RB, <i>et al<\/i>. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.","DOI":"10.1016\/j.euje.2005.12.014"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ponikowski P, Voors AA, Anker SD, <i>et al<\/i>. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yancy CW, Jessup M, Bozkurt B, <i>et al<\/i>. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147-239.","DOI":"10.1016\/j.jacc.2013.05.019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. von Elm E, Altman DG, Egger M, <i>et al<\/i>. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806-8.","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mueller C, Scholer A, Laule-Kilian K, <i>et al<\/i>. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-54.","DOI":"10.1056\/NEJMoa031681"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Vorselaars AD, van Moorsel CH, Zanen P, <i>et al<\/i>. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir Med 2015; 109: 279-85.","DOI":"10.1016\/j.rmed.2014.11.009"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bima A, Sikaris K. Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays. Intern Med J 2012; 42: 16-22.","DOI":"10.1111\/j.1445-5994.2012.02893.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012; 33: 579-86.","DOI":"10.1093\/eurheartj\/ehr492"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Doi Y, Ninomiya T, Hata J, <i>et al<\/i>. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study. Arterioscler Thromb Vasc Biol 2011; 31: 2997-3003.","DOI":"10.1161\/ATVBAHA.111.223669"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takeishi Y. Biomarkers in heart failure. Int Heart J 2014; 55: 474-81.","DOI":"10.1536\/ihj.14-267"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Iwanaga Y, Nishi I, Furuichi S, <i>et al<\/i>. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-8.","DOI":"10.1016\/j.jacc.2005.11.030"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nakamura Y, Yoshihisa A, Takiguchi A, <i>et al<\/i>. High-sensitivity cardiac troponin t predicts non-cardiac mortality in heart failure. Circ J 2014; 78: 890-5.","DOI":"10.1253\/circj.CJ-13-1372"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Myoren T, Kobayashi S, Oda S, <i>et al<\/i>. An oxidative stress biomarker, urinary 8-hydroxy-2&apos;-deoxyguanosine, predicts cardiovascular-related death after steroid therapy for patients with active cardiac sarcoidosis. Int J Cardiol 2016; 212: 206-13.","DOI":"10.1016\/j.ijcard.2016.03.003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kobayashi S, Myoren T, Oda S, <i>et al<\/i>. Urinary 8-hydroxy-2&apos;-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis. Int J Cardiol 2015; 190: 319-28.","DOI":"10.1016\/j.ijcard.2015.04.144"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-695\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T02:06:04Z","timestamp":1661738764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-695\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-695","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}